1
|
Salles N, Saillour-Glénisson F, Sibe M, Langlois E, Kret M, Durrieu J, Arditi N, Abraham M, Perry F. Effectiveness and organizational conditions of effectiveness of telemedicine in nursing homes. A study protocol of a comparative prospective cohort (EFFORT study). Digit Health 2021; 7:2055207620982422. [PMID: 33598307 PMCID: PMC7841670 DOI: 10.1177/2055207620982422] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2020] [Accepted: 12/01/2020] [Indexed: 11/17/2022] Open
Abstract
The profile of nursing home (NH) residents has changed over the past decade with more dependency, more severe chronic diseases and more treatments prescribed. For residents, the major consequence is the higher risk of unplanned hospitalization. French guidelines recommend the development of interactive telemedicine (InT) in NHs in order to improve access to care, and to decrease the rate of avoidable unplanned hospitalizations. Methods and analysis: The aim of this study is to analyze the impact of an InT protocol delivered in NHs on the rate of unplanned hospitalizations, and on the quality of life at work and the organizational conditions of effectiveness of telemedicine in NHs. We will perform a mixed methods study combining a cluster non-randomized controlled trial in two matched parallel arms (telemedicine group and control group) and qualitative analysis of the evolution of organizational and professional contexts in NHs. Ethics and dissemination: The study protocol was approved and sponsored by the French Ministry of Health. The study received ethical approval from the Bordeaux University Hospital Institutional Review Board. We will communicate the final results to the public via conferences and results will also be submitted for publication in international peer-reviewed scientific journals. Trial registration number NCT03486977
Collapse
Affiliation(s)
- Nathalie Salles
- Pole de Gérontologie Clinique, CHU Bordeaux, Bordeaux, France
| | - Florence Saillour-Glénisson
- Unité de Soutien Méthodologique à la Recherche Clinique et Épidémiologique du CHU de Bordeaux, Bordeaux, France
| | - Matthieu Sibe
- Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED), Université de Bordeaux, Bordeaux, France
| | - Emmanuel Langlois
- Centre Emile Durkheim, Science Politique et Sociologie Comparatives (UMR 5116), Université de Bordeaux, Bordeaux, France
| | - Marion Kret
- Unité de Soutien Méthodologique à la Recherche Clinique et Épidémiologique du CHU de Bordeaux, Bordeaux, France
| | - Jessica Durrieu
- Pole de Gérontologie Clinique, CHU Bordeaux, Bordeaux, France
| | - Nora Arditi
- Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED), Université de Bordeaux, Bordeaux, France
| | - Maelys Abraham
- Centre Emile Durkheim, Science Politique et Sociologie Comparatives (UMR 5116), Université de Bordeaux, Bordeaux, France
| | - Frederic Perry
- Recherche Clinique et de l'Innovation, CHU Bordeaux, Bordeaux, France
| |
Collapse
|
2
|
Roubaud Baudron C, Legeron R, Ollivier J, Bonnet F, Greib C, Guerville F, Cazanave C, Kobeh D, Cressot V, Moneger N, Videau MN, Thiel E, Foucaud C, Lafargue A, de Thezy A, Durrieu J, Bourdel Marchasson I, Pinganaud G, Breilh D. Is the subcutaneous route an alternative for administering ertapenem to older patients? PHACINERTA study. J Antimicrob Chemother 2020; 74:3546-3554. [PMID: 31730164 DOI: 10.1093/jac/dkz385] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2019] [Revised: 08/02/2019] [Accepted: 08/06/2019] [Indexed: 12/30/2022] Open
Abstract
BACKGROUND Antibiotic administration by subcutaneous (SC) injection is common practice in French geriatric wards as an alternative to the intravenous (IV) route, but few pharmacokinetic/pharmacodynamic data are available. Ertapenem is useful for the treatment of infections with ESBL-producing enterobacteria. OBJECTIVES To report and compare ertapenem pharmacokinetic data between IV and SC routes in older persons. METHODS Patients >65 years of age receiving ertapenem (1 g once daily) for at least 48 h (IV or SC, steady-state) were prospectively enrolled. Total ertapenem concentrations [residual (C0), IV peak (C0.5) and SC peak (C2.5)] were determined by UV HPLC. Individual-predicted AUC0-24 values were calculated and population pharmacokinetic analyses were performed. Using the final model, a Monte Carlo simulation involving 10 000 patients evaluated the influence of SC or IV administration on the PTA. Tolerance to ertapenem and recovery were also monitored. ClinicalTrials.gov identifier: NCT02505386. RESULTS Ten (mean ± SD age=87±7 years) and 16 (age=88±5 years) patients were included in the IV and SC groups, respectively. The mean C0 and C2.5 values were not significantly different between the IV and SC groups (C0=12±5.9 versus 12±7.4 mg/L, P=0.97; C2.5=97±42 versus 67±41 mg/L, P=0.99). The mean C0.5 was higher in the IV group compared with the SC group (C0.5=184±90 versus 51±66 mg/L, P=0.001). The mean individual AUCs (1126.92±334.99 mg·h/L for IV versus 1005.3±266.0 mg·h/L for SC, P=0.38) and PTAs were not significantly different between groups. No severe antibiotic-related adverse effects were noted. CONCLUSIONS SC administration of ertapenem is an alternative to IV administration in older patients.
Collapse
Affiliation(s)
- Claire Roubaud Baudron
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France.,Univ. Bordeaux, INSERM UMR 1053, BaRITOn, F-33000 Bordeaux, France
| | - Rachel Legeron
- CHU Bordeaux, Service Pharmacie à Usage Intérieur, département de Pharmacie Clinique, F-33000 Bordeaux, France
| | - Julien Ollivier
- CHU Bordeaux, Service Pharmacie à Usage Intérieur, département de Pharmacie Clinique, F-33000 Bordeaux, France
| | - Fabrice Bonnet
- CHU Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Sain-André, F-33000 Bordeaux, France
| | - Carine Greib
- CHU Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Hôpital Haut Lévêque, F-33000 Bordeaux, France
| | - Florent Guerville
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France
| | - Charles Cazanave
- CHU Bordeaux, Service des Maladies Infectieuses et Tropicales, Hôpital Pellegrin, F-33000 Bordeaux, France.,Univ. Bordeaux, INRA, USC EA 3671, Infections humaines à mycoplasmes et à chlamydiae, F-33000 Bordeaux, France
| | - David Kobeh
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France
| | - Véronique Cressot
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France
| | - Nicolas Moneger
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France
| | | | - Elise Thiel
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France
| | - Carine Foucaud
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France
| | - Aurélie Lafargue
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France
| | - Albane de Thezy
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France
| | - Jessica Durrieu
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France
| | - Isabelle Bourdel Marchasson
- CHU Bordeaux, Pôle de Gérontologie Clinique, F-33000 Bordeaux, France.,Univ. Bordeaux, CNRS UMR 5536 RMSB, F-33000 Bordeaux, France
| | | | - Dominique Breilh
- CHU Bordeaux, Service Pharmacie à Usage Intérieur, département de Pharmacie Clinique, F-33000 Bordeaux, France.,Univ. Bordeaux, INSERM UMR 1034, Pharmacokinetics and Pharmacodynamics (PK/PD) Group, F-33000 Bordeaux, France
| |
Collapse
|
3
|
Bourdel-Marchasson I, Ostan R, Regueme SC, Pinto A, Pryen F, Charrouf Z, d’Alessio PA, Roubaud Baudron C, Guerville F, Durrieu J, Donini LM, Franceschi C, Valentini L. Quality of Life: Psychological Symptoms-Effects of a 2-Month Healthy Diet and Nutraceutical Intervention; A Randomized, Open-Label Intervention Trial (RISTOMED). Nutrients 2020; 12:nu12030800. [PMID: 32197408 PMCID: PMC7146172 DOI: 10.3390/nu12030800] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2020] [Revised: 03/01/2020] [Accepted: 03/16/2020] [Indexed: 01/15/2023] Open
Abstract
Depression symptoms and lower health-related quality of life (HRQoL) are associated with inflammation. This multicenter dietary intervention was shown to reduce inflammation in older people. This was the main outcome. Here, we describe the effects on HRQoL, anxiety, and depressive symptoms according to inflammation status. Overall, 125 healthy older subjects (65–80 year) were recruited (Italy, France, and Germany) and randomized into four arms (A, Healthy diet (HD); B, HD plus De Simone Formulation probiotic blend; C, HD plus AISA d-Limonene; D, HD plus Argan oil). The HD was weight maintaining, rich in antioxidant vitamins, polyphenols, polyunsaturated fatty acids (n6: n3 ratio = 3:1), and fiber. Data on inflammatory parameters, mental (MCS) and physical (PCS) component summaries of HRQoL (SF−36), anxiety symptoms (STAI state), and depressive symptoms (CES-D) were collected before and after 56 days of intervention. Body fat mass proportion (BFM) was considered a co-variable. A decrease of CES-D score was seen in the four arms (A: −40.0%, p = 0.001; B: −32.5%, p = 0.023; C: −42.8%, p = 0.004; and D: −33.3%, p = 0.21). Within the subgroups of subjects with medium/high inflammation a similar decrease in CES-D score occurred in all groups (A: −44.8%, p = 0.021; B, −46.7%, p = 0.024; C, −52.2%, p = 0.039; D, −43.8%, p = 0.037). The effect of interventions on CES-D was not related to baseline inflammation. MCS-HRQoL improved in A and C. There was no change in anxiety or PCS-HRQoL. In this trial with no control group, a decrease in depressive symptoms in healthy older volunteers was observed after a 2-month healthy diet intervention, independently of inflammation but with possible limitations due to participation.
Collapse
Affiliation(s)
- Isabelle Bourdel-Marchasson
- CRMSB UMR 5536, Université Bordeaux/CNRS, F−33000 Bordeaux, France
- CHU Bordeaux, Pôle de Gérontologie, Bordeaux, F−33000 Bordeaux, France; (S.C.R.); (C.R.B.); (F.G.); (J.D.)
- Correspondence: ; Tel.: +33-55-765-6571
| | - Rita Ostan
- Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40126 Bologna, Italy; (R.O.); (C.F.)
| | - Sophie C Regueme
- CHU Bordeaux, Pôle de Gérontologie, Bordeaux, F−33000 Bordeaux, France; (S.C.R.); (C.R.B.); (F.G.); (J.D.)
| | - Alessandro Pinto
- Experimental Medicine Department, Sapienza University of Rome, 00185 Rome, Italy; (A.P.); (L.M.D.)
| | - Florence Pryen
- Mendes SA, Via Giacometti 1, CH−6900 Lugano, Switzerland;
| | - Zoubida Charrouf
- Department of Chemistry, University Mohammed V, Rabat BP 1014, Morocco;
| | - Patrizia A d’Alessio
- AISA (Anti-Inflammatory Senescence Actives) Therapeutics, Genopole Entreprises 91058 Evry, France;
| | - Claire Roubaud Baudron
- CHU Bordeaux, Pôle de Gérontologie, Bordeaux, F−33000 Bordeaux, France; (S.C.R.); (C.R.B.); (F.G.); (J.D.)
- Université Bordeaux, INSERM UMR 1053, BaRITon, F−33000 Bordeaux, France
| | - Florent Guerville
- CHU Bordeaux, Pôle de Gérontologie, Bordeaux, F−33000 Bordeaux, France; (S.C.R.); (C.R.B.); (F.G.); (J.D.)
| | - Jessica Durrieu
- CHU Bordeaux, Pôle de Gérontologie, Bordeaux, F−33000 Bordeaux, France; (S.C.R.); (C.R.B.); (F.G.); (J.D.)
| | - Lorenzo M Donini
- Experimental Medicine Department, Sapienza University of Rome, 00185 Rome, Italy; (A.P.); (L.M.D.)
| | - Claudio Franceschi
- Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, 40126 Bologna, Italy; (R.O.); (C.F.)
- Department of Applied Mathematics, Lobachevsky University, Nizhny Novgorod 603950, Russia
| | - Luzia Valentini
- Department Gastroenterology and Hepatology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany;
- Neubrandenburg Institute of Evidence-Based Dietetics (NIED), University of Applied Sciences, 17033 Neubrandenburg, Germany
| |
Collapse
|
4
|
Arrieta H, Astrugue C, Regueme S, Durrieu J, Maillard A, Rieger A, Terrebonne E, Laurent C, Maget B, Servent V, Lavau-Denès S, Dauba J, Fonck M, Thiébaut R, Bourdel-Marchasson I. Effects of a physical activity programme to prevent physical performance decline in onco-geriatric patients: a randomized multicentre trial. J Cachexia Sarcopenia Muscle 2019; 10:287-297. [PMID: 30829460 PMCID: PMC6463460 DOI: 10.1002/jcsm.12382] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/24/2018] [Accepted: 11/20/2018] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND Older adults with cancer experience negative long-term functional effects of both cancer and treatments. Exercise may minimize their age-related and cancer-related functional decline. METHODS We conducted a multicentre open-label 12 month randomized clinical trial with two parallel arms including participants aged ≥70 years with lymphoma or carcinoma requiring curative treatment. The study started at the beginning of any phase of cancer treatment (surgery, chemotherapy, or radiotherapy). The usual care group (UCG) received the current national recommendations in physical activity (a guideline without specific counselling). The intervention group (IG) received 1 year phoned physical activity advice individually adapted to physical assessment (twice a month during the first 6 months and then monthly). The primary outcome was the proportion of subjects with a 1 year decreased short physical performance battery (SPPB) score of 1 point or more. Physical, cognitive, and clinical secondary outcomes were also investigated. RESULTS We allocated 301 participants (age 76.7 ± 5.0, female 60.6%) to each group. At baseline, the median SPPB was 10/12 in both groups. Breast was the most frequent tumour site (35.7%). After 1 year, 14.0% of participants in the UCG and 18.7% in the IG had a decrease in SPPB score of 1 point or more (P = 0.772). At 2 years, there was no difference in SPPB, gait speed, International Physical Activity Questionnaire score, and verbal fluency. Subgroup analyses after 2 years showed a decline in SPPB for 29.8% of UCG and 5.0% of IG breast cancer participants (P = 0.006), in 21.7% of UCG and 6.2% of IG female participants (P = 0.019), and in 24.5% of UCG and 11.1% of IG normal nutritional status participants (P = 0.009). Falls, hospitalization, institutionalization, and death rates were similar in both groups. CONCLUSIONS Personalized phoned physical activity advice had not reduced functional decline at 1 year but provided preliminary evidence that may prevent physical performance decline at 2 years in older adults with breast cancer.
Collapse
Affiliation(s)
- Haritz Arrieta
- Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.,CNRS, RMSB, UMR 5536, Bordeaux, France.,University of Bordeaux, RMSB, UMR 5536, Bordeaux, France
| | - Cyril Astrugue
- Pole de Santé Publique, Service d'Information Médicale, Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique, CHU de Bordeaux, Bordeaux, France
| | - Sophie Regueme
- Pôle de gérontologie clinique, CHU de Bordeaux, Bordeaux, France
| | - Jessica Durrieu
- Pôle de gérontologie clinique, CHU de Bordeaux, Bordeaux, France
| | - Aline Maillard
- Pole de Santé Publique, Service d'Information Médicale, Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique, CHU de Bordeaux, Bordeaux, France
| | - Alban Rieger
- Pôle de gérontologie clinique, CHU de Bordeaux, Bordeaux, France
| | - Eric Terrebonne
- Pôle appareil digestif, endocrinologie et nutrition, CHU de Bordeaux, Bordeaux, France
| | - Christophe Laurent
- Pôle appareil digestif, endocrinologie et nutrition, CHU de Bordeaux, Bordeaux, France
| | | | | | | | | | | | - Rodolphe Thiébaut
- Pole de Santé Publique, Service d'Information Médicale, Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique, CHU de Bordeaux, Bordeaux, France
| | - Isabelle Bourdel-Marchasson
- CNRS, RMSB, UMR 5536, Bordeaux, France.,University of Bordeaux, RMSB, UMR 5536, Bordeaux, France.,Pôle de gérontologie clinique, CHU de Bordeaux, Bordeaux, France
| |
Collapse
|
5
|
Arrieta H, Durrieu J, Ratsimbazafy F, Irazusta J, Bourdel-Marchasson I. Association of physical performance, physical activity or nutritional status with health related fatigue and function in older patient treated for cancer. Clin Nutr 2018. [DOI: 10.1016/j.clnu.2018.06.1335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
6
|
Arrieta H, Astrugue C, Regueme S, Durrieu J, Maillard A, Becouarn Y, Terrebonne E, Laurent C, Maget B, Servent V, Lavau-Denès S, Dauba J, Fonck M, Thiébaut R, Bourdel-Marchasson I. Randomized clinical trial of telephoned-based physical activity intervention in onco-geriatric patients. J Clin Oncol 2018. [DOI: 10.1200/jco.2018.36.15_suppl.10031] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Haritz Arrieta
- Department of Physiology, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain, Leioa (Bizkaia), Spain
| | - Cyril Astrugue
- Pole de Santé Publique, Service d’Information Médicale, Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique, CHU de Bordeaux, Bordeaux, France
| | - Sophie Regueme
- Pole de gérontologie clinique, CHU de Bordeaux, Bordeaux, France
| | - Jessica Durrieu
- Pole de gérontologie clinique, CHU de Bordeaux, Bordeaux, France
| | - Aline Maillard
- Pole de Santé Publique, Service d’Information Médicale, Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique, CHU de Bordeaux, Bordeaux, France
| | | | - Eric Terrebonne
- Pôle Appareil Digestif, Endocrinologie et Nutrition CHU de Bordeaux, Bordeaux, France
| | - Christophe Laurent
- Pôle Appareil Digestif, Endocrinologie et Nutrition CHU de Bordeaux, Bordeaux, France
| | | | | | | | | | | | - Rodolphe Thiébaut
- Pole de Santé Publique, Service d’Information Médicale, Unité de Soutien Méthodologique à la Recherche Clinique et Epidémiologique, CHU de Bordeaux, Bordeaux, France
| | | |
Collapse
|
7
|
Regueme S, Ostan R, Pinto A, Valentini L, Durrieu J, Blanc-Bisson C, Donini L, Lochs H, Franceschi C, Bourdel-Marchasson I. SUN-P108: Effects of a 2-Month Dietand Nutraceutical Intervention on Quality of Life and Depression with Respect to Inflammaging: Ristomed, an Open Label Intervention Trial. Clin Nutr 2016. [DOI: 10.1016/s0261-5614(16)30451-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
8
|
Durrieu J, Doussau A, Rieger A, Terrebonne E, Bouabdallah K, Zwolakowski MD, Maget B, Dauba J, Mariette C, Trager S, Périé JL, Robert B, Regueme SC, Bourdel-Marchasson I. Design of a Physical Activity Program to Prevent Functional Decline in Onco-Geriatric Patients (CAPADOGE): A Randomized Multicenter Trial. J Frailty Aging 2016; 1:138-43. [PMID: 27093202 DOI: 10.14283/jfa.2012.22] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
BACKGROUND Cancer in older patient favours the development of frailty: feeling of exhaustion, loss of weight, decreased muscle strength, slow gait speed, and low physical activity. OBJECTIVES To evaluate the efficacy of adapted physical activity phone advices in limiting the cancer-induced loss of autonomy and frailty phenotype development. DESIGN Multicenter randomized controlled trial. SETTING Patients (>70y) undergoing curative treatment for cancer (n=400) will be recruited from 12 centres. INTERVENTION The intervention consists in phoned personalized physical activity advices related to strength, aerobic, balance, proprioception, and flexibility. The contacts are performed twice a month during six months and then monthly until 1 year. The intervention complements the PNNS booklet advices (National Nutritional Health Program). The trial compares «individualized phone advices + PNNS» to «usual care + PNNS». MEASUREMENTS Functional, cognitive, clinical and self-reported data are assessed before treatment and at 3, 6, 12, 18, and 24 month follow-up. The primary outcome is the proportion of subjects with a one-year decreased SPPB (Short Physical Performance Battery) score of one point or more, as compared to baseline. The secondary outcomes include quality of life items, rate of hospitalizations, institutionalizations, mortality, Fried phenotype at 1 and 2 years, and the SPPB score at 2 years. DISCUSSION This large trial will provide clinical data of the effects of an exercise advices intervention in older patients during cancer therapy on function and cognition evolution, and quality of life. The possibilities of minimizing the development of frailty phenotype due to these advices will be explored.
Collapse
Affiliation(s)
- J Durrieu
- Isabelle Bourdel-Marchasson, Département de gériatrie, Hôpital Xavier Arnozan, Centre Henri Choussat, Avenue du Haut-Lévêque, 33604 Pessac cedex, France. Phone: (+33) 557 65 65 71, Fax: (+33) 557 65 65 60, E-mail:
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Valentini L, Pinto A, Bourdel-Marchasson I, Ostan R, Brigidi P, Turroni S, Hrelia S, Hrelia P, Bereswill S, Fischer A, Leoncini E, Malaguti M, Blanc-Bisson C, Durrieu J, Spazzafumo L, Buccolini F, Pryen F, Donini LM, Franceschi C, Lochs H. Impact of personalized diet and probiotic supplementation on inflammation, nutritional parameters and intestinal microbiota - The "RISTOMED project": Randomized controlled trial in healthy older people. Clin Nutr 2014; 34:593-602. [PMID: 25453395 DOI: 10.1016/j.clnu.2014.09.023] [Citation(s) in RCA: 73] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2014] [Revised: 07/23/2014] [Accepted: 09/29/2014] [Indexed: 02/06/2023]
Abstract
OBJECTIVES To assess the impact of a personalized diet, with or without addition of VSL#3 preparation, on biomarkers of inflammation, nutrition, oxidative stress and intestinal microbiota in 62 healthy persons aged 65-85 years. DESIGN Open label, randomized, multicenter study. PRIMARY ENDPOINT High-sensitivity C-reactive protein. SETTING Community. INTERVENTIONS Eight week web-based dietary advice (RISTOMED platform) alone or with supplementation of VSL#3 (2 capsules per day). The RISTOMED diet was optimized to reduce inflammation and oxidative stress. MEASUREMENTS Blood and stool samples were collected on days 1 and 56. RESULTS Diet alone reduced ESR (p = 0.02), plasma levels of cholesterol (p < 0.01) and glucose (p = 0.03). Addition of VSL#3 reduced ESR (p = 0.05) and improved folate (p = 0.007), vitamin B12 (p = 0.001) and homocysteine (p < 0.001) plasma levels. Neither intervention demonstrated any further effects on inflammation. Subgroup analysis showed 40 participants without signs of low-grade inflammation (hsCRP<3 mg/l, subgroup 1) and 21 participants with low-grade inflammation at baseline (hsCRP≥3 mg/l, subgroup 2). In subgroup 2 addition of VSL#3 increased bifidobacteria (p = 0.005) in more participants and improved both folate (p = 0.015) and vitamin B12 (p = 0.035) levels compared with subgroup 1. The increases were positively correlated to the change in the bifidobacteria concentration for folate (p = 0.023) and vitamin B12 (p = 0.001). As expected change in homocysteine correlated negatively to change in folate (r = -0.629, p = 0.002) and vitamin B12 (r = -0.482, p = 0.026). CONCLUSIONS Addition of VSL#3 increased bifidobacteria and supported adequate folate and vitamin B12 concentrations in subjects with low-grade inflammation. Decrease in homocysteine with VSL#3 was clinically relevant. suggesting protective potentials for aging-associated conditions, e.g. cardiovascular or neurological diseases. ClinicalTrials.gov: NCT01069445-NCT01179789.
Collapse
Affiliation(s)
- Luzia Valentini
- Dept Gastroenterology and Hepatology, Charité-Universitätsmedizin Berlin, CCM, Charitéplatz 1, 10117 Berlin, Germany.
| | - Alessandro Pinto
- Experimental Medicine Department, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
| | - Isabelle Bourdel-Marchasson
- CHU Bordeaux, Clinical Gerontology, France; CNRS, RMSB, UMR 5536, France; University Bordeaux, RMSB, UMR 5536, Bordeaux, France
| | - Rita Ostan
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via S. Giacomo 12, 40126 Bologna, Italy
| | - Patrizia Brigidi
- Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy
| | - Silvia Turroni
- Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy
| | - Silvana Hrelia
- Dept Life Quality Studies, Alma Mater Studiorum University of Bologna, Via Irnerio 48, 40126 Bologna, Italy
| | - Patrizia Hrelia
- Department of Pharmacy and Biotechnology, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy
| | - Stefan Bereswill
- Dept Microbiology and Hygiene, Charité-Universitätsmedizin Berlin, CBF, Hindenburgdamm 27, 12203 Berlin, Germany
| | - André Fischer
- Dept Microbiology and Hygiene, Charité-Universitätsmedizin Berlin, CBF, Hindenburgdamm 27, 12203 Berlin, Germany
| | - Emanuela Leoncini
- Dept Life Quality Studies, Alma Mater Studiorum University of Bologna, Via Irnerio 48, 40126 Bologna, Italy
| | - Marco Malaguti
- Dept Life Quality Studies, Alma Mater Studiorum University of Bologna, Via Irnerio 48, 40126 Bologna, Italy
| | | | | | - Liana Spazzafumo
- Biostatistical Center INRCA, Via S. Margherita 5, 60100 Ancona, Italy
| | - Fabio Buccolini
- R&D, VoxNet CEO, Via Giovanni Paisiello 32, 00198 Rome, Italy
| | - Florence Pryen
- Actial Farmaceutica Lda, Praca Severiano Ferraz 258, 09000 082 Funchal, Portugal
| | - Lorenzo Maria Donini
- Experimental Medicine Department, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
| | - Claudio Franceschi
- Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Via S. Giacomo 12, 40126 Bologna, Italy
| | - Herbert Lochs
- Experimental Medicine Department, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy; Medical University of Innsbruck, Innrain 52, 6020 Innsbruck, Austria
| |
Collapse
|
10
|
Bourdel-Marchasson I, Durrieu J, Doussau A, Germain C, Blanc JF, Lahmar C, Dauba J, Terrebonne E, Lecaille C, Ceccaldi J, Cany L, Lavau-Denes S, Chomy F, Houede N, Soubeyran P, Blanc-Bisson C, Fonck M. Nutritional Advices in Older Patients at Risk for Malnutrition During Chemotherapy for Cancer: No Effect on Mortality Decreased Rate or Severe Infections. Multicentre Inogad Study. J Geriatr Oncol 2013. [DOI: 10.1016/j.jgo.2013.09.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
11
|
Durrieu J, Blanc-Bisson C, Fonck M, Béchade D, Becouarn Y, Blanc JF, Ceccaldi J, Chomy F, Houédé N, Lécaille C, Smith D, Soubeyran P, Terrebonne E, Vergnol J, Bourdel-Marchasson I. Huit fiches pratiques de conseil nutritionnel pour répondre aux besoins des patients âgés au cours de leur traitement de chimiothérapie: étude INOGAD. ONCOLOGIE 2011. [DOI: 10.1007/s10269-011-1985-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
12
|
Blanc-Bisson C, Fonck M, Germain C, Durrieu J, Chêne G, Bourdel-Marchasson I. Faisabilité du dépistage nutritionnel dans le cadre de l’étude Inogad. Rev Epidemiol Sante Publique 2009. [DOI: 10.1016/j.respe.2009.02.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
13
|
Blanc-Bisson C, Blanc J, Houédé N, Mertens C, Lahmar C, Becerro-Hallard M, Laveau-Denès S, Labrousse A, Terrebonne E, Lécaille C, Floccia M, Durrieu J, Soubeyran P, Rainfray M, Fonck M, Bourdel-Marchasson I. Nutritional intervention in elderly patients with cancer treated by chemotherapy. An interventional randomized study. Crit Rev Oncol Hematol 2008. [DOI: 10.1016/s1040-8428(08)70082-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
14
|
Durrieu J, Argillier JF, Rosenberg E, Li Y. Static and Dynamic Filtration Properties of Aqueous Suspensions of Clays and Electrolytes. ACTA ACUST UNITED AC 2006. [DOI: 10.2516/ogst:1997020] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
15
|
Secchiutti A, Fagour C, Perlemoine C, Gin H, Durrieu J, Rigalleau V. Air displacement plethysmography can detect moderate changes in body composition. Eur J Clin Nutr 2006; 61:25-9. [PMID: 16855541 DOI: 10.1038/sj.ejcn.1602482] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVES To determine the sensitivity of air displacement plethysmography (APD) for evaluation of changes in body composition in normal subjects. DESIGN Comparison of measurements with and without oil or water loads. SUBJECTS AND METHODS Ten healthy volunteers were analyzed, without and with 1 l and 2 l of oil or water. The measured and true changes in fat mass and fat-free mass were compared by paired t-tests. A correlation study and a Bland & Altman procedure was performed on the 60 measurements of adiposity changes in 30 subjects carrying 0.5 l (n=8 x 2), 1 l (n=10 x 2) and 2 l (n=12 x 2) oil and water loads. RESULTS Fat-free mass increased when the 10 subjects were carrying water. When they carried oil, fat mass increased, however, a approximately 0.5 kg increase of fat-free mass was also detected. Two liters loads led to distinct changes: +1.49+/-0.59 kg fat and +0.50+/-0.60 kg fat-free with oil and +0.37+/-0.57 kg fat and +1.70+/-0.56 kg fat-free with water (both P<0.001). Mixed loads (+1 l oil and 1 l water) led to detect +0.85+/-0.48 kg fat and +1.09+/-0.45 kg fat-free (both P<0.005 vs without load). For the 30 subjects analyzed thrice, measured changes in fat and fat-free mass were slightly underestimated (-15%, NS) but correlated with the true changes. Measured changes in adiposity were correlated with the true changes, with no bias as indicated by the Bland & Altman procedure. CONCLUSION APD detects approximately 2 kg changes in fat or fat-free mass in small populations.
Collapse
Affiliation(s)
- A Secchiutti
- Nutrition-Diabétologie, USN, Hopital Haut-Lévêque, Pessac, France
| | | | | | | | | | | |
Collapse
|